Hollander E - Search Results

1

Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder.

Berlin HA, Koran LM, Jenike MA, Shapira NA, Chaplin W, Pallanti S, Hollander E. Berlin HA, et al. Among authors: hollander e. J Clin Psychiatry. 2011 May;72(5):716-21. doi: 10.4088/JCP.09m05266gre. Epub 2010 Aug 10. J Clin Psychiatry. 2011. PMID: 20816027 Clinical Trial.

2

Venlafaxine in treatment-resistant obsessive-compulsive disorder.

Hollander E, Friedberg J, Wasserman S, Allen A, Birnbaum M, Koran LM. Hollander E, et al. J Clin Psychiatry. 2003 May;64(5):546-50. doi: 10.4088/jcp.v64n0508. J Clin Psychiatry. 2003. PMID: 12755657 Clinical Trial.

3

A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder.

Hollander E, Koran LM, Goodman WK, Greist JH, Ninan PT, Yang H, Li D, Barbato LM. Hollander E, et al. J Clin Psychiatry. 2003 Jun;64(6):640-7. doi: 10.4088/jcp.v64n0604. J Clin Psychiatry. 2003. PMID: 12823077 Clinical Trial.

4

Risperidone augmentation in treatment-resistant obsessive-compulsive disorder: a double-blind, placebo-controlled study.

Hollander E, Baldini Rossi N, Sood E, Pallanti S. Hollander E, et al. Int J Neuropsychopharmacol. 2003 Dec;6(4):397-401. doi: 10.1017/S1461145703003730. Int J Neuropsychopharmacol. 2003. PMID: 14604454 Free article. Clinical Trial.

5

A qualitative analysis of nonresponse: management of treatment-refractory obsessive-compulsive disorder.

Pallanti S, Hollander E, Goodman WK. Pallanti S, et al. Among authors: hollander e. J Clin Psychiatry. 2004;65 Suppl 14:6-10. J Clin Psychiatry. 2004. PMID: 15554782 Review.

6

Serotonin-1D hypothesis of obsessive-compulsive disorder: an update.

Zohar J, Kennedy JL, Hollander E, Koran LM. Zohar J, et al. Among authors: hollander e. J Clin Psychiatry. 2004;65 Suppl 14:18-21. J Clin Psychiatry. 2004. PMID: 15554784 Review.

7

Does sustained-release lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders?

Hollander E, Pallanti S, Allen A, Sood E, Baldini Rossi N. Hollander E, et al. Am J Psychiatry. 2005 Jan;162(1):137-45. doi: 10.1176/appi.ajp.162.1.137. Am J Psychiatry. 2005. PMID: 15625212 Clinical Trial.

8

Neurological soft signs as predictors of treatment response to selective serotonin reuptake inhibitors in obsessive-compulsive disorder.

Hollander E, Kaplan A, Schmeidler J, Yang H, Li D, Koran LM, Barbato LM. Hollander E, et al. J Neuropsychiatry Clin Neurosci. 2005 Fall;17(4):472-7. doi: 10.1176/jnp.17.4.472. J Neuropsychiatry Clin Neurosci. 2005. PMID: 16387985 Clinical Trial.

9

Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.

Wasserman S, Iyengar R, Chaplin WF, Watner D, Waldoks SE, Anagnostou E, Soorya L, Hollander E. Wasserman S, et al. Among authors: hollander e. Int Clin Psychopharmacol. 2006 Nov;21(6):363-7. doi: 10.1097/01.yic.0000224787.13782.0f. Int Clin Psychopharmacol. 2006. PMID: 17012983

10

Escitalopram in the treatment of impulsive-compulsive internet usage disorder: an open-label trial followed by a double-blind discontinuation phase.

Dell'Osso B, Hadley S, Allen A, Baker B, Chaplin WF, Hollander E. Dell'Osso B, et al. Among authors: hollander e. J Clin Psychiatry. 2008 Mar;69(3):452-6. doi: 10.4088/jcp.v69n0316. J Clin Psychiatry. 2008. PMID: 18312057 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

574 results

Search Page

Filters